Effect of serotonin and throm☐ane A2 on endothelial cell proliferation: Effect of specific receptor antagonists

作者: Rajbabu Pakala , Claude R. Benedict

DOI: 10.1016/S0022-2143(98)90061-0

关键词: NeointimaInternal medicineEndocrinologyBiologyReceptorVascular endothelial growth factor AReceptor antagonistEndothelial stem cellPlatelet-derived growth factor receptorVascular smooth muscleCell growth

摘要: Abstract Platelet aggregation at sites of vascular injury releases both peptide growth factors and vasoactive compounds. Although significant attention has been focused on factors, very little is known about the mitogenic effect We evaluated serotonin (5-HT) throm☐ane A2 (TXA2) mimetic U46619 alone in combination aortic endothelial cells. Stimulation cells by 5-HT resulted an increase tritiated thymidine uptake cell number, whereas did not have any effect. However, when were exposed to compounds, potentiated When preincubated with LY281067 (a 5-HT2 receptor antagonist) or ridogrel combined TXA2 synthase inhibitor antagonist), blocked potentiating 5-HT2-induced incorporation. antagonists, effects blocked. Recent studies indicated that regenerating may release for smooth muscle cells, leading proliferation development neointima. This study suggests use antagonists inhibit attenuate formation

参考文章(37)
C. Betsholtz, J. S. Pober, A. Hammacher, T. Collins, M. A. Gimbrone, C. H. Heldin, B. Westermark, Cultured human endothelial cells express platelet-derived growth factor A chain. American Journal of Pathology. ,vol. 126, pp. 7- 12 ,(1987)
G.W. Dorn, M.W. Becker, M.G. Davis, Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle. Journal of Biological Chemistry. ,vol. 267, pp. 24897- 24905 ,(1992) , 10.1016/S0021-9258(18)35848-4
C J Parli, M L Cohen, R W Fuller, 5-Hydroxytryptamine2 receptor antagonist activity of the acid metabolite (1-isopropyl dihydrolysergic acid) of the ergoline ester, sergolexole (LY281067). Journal of Pharmacology and Experimental Therapeutics. ,vol. 251, pp. 1006- 1011 ,(1989)
V.L. Porter-Fink, Frederic E. Eckhauser, 111In-8-hydroxyquinoline platelet labeling in dogs Journal of Surgical Research. ,vol. 31, pp. 87- 92 ,(1981) , 10.1016/0022-4804(81)90034-2
T Ishimitsu, Y Uehara, M Ishii, T Ikeda, H Matsuoka, T Sugimoto, Thromboxane and vascular smooth muscle cell growth in genetically hypertensive rats. Hypertension. ,vol. 12, pp. 46- 51 ,(1988) , 10.1161/01.HYP.12.1.46
Y Oka, D N Orth, Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets. Journal of Clinical Investigation. ,vol. 72, pp. 249- 259 ,(1983) , 10.1172/JCI110964
G. Ferns, E. Raines, K. Sprugel, A. Motani, M. Reidy, R. Ross, Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science. ,vol. 253, pp. 1129- 1132 ,(1991) , 10.1126/SCIENCE.1653454
M.Nasir Hussain, Claude R. Benedict, Radioenzymatic microassay for picogram quantities of serotonin or acetylserotonin in biological fluids and tissues Biochemical Medicine and Metabolic Biology. ,vol. 37, pp. 314- 322 ,(1987) , 10.1016/0885-4505(87)90042-9